Publications by authors named "Graham Blakey"

Claim this Profile
P
Publisher Correction: Developing the Clarity and Openness in Reporting: E3-based (CORE) Reference user manual for creation of clinical study reports in the era of clinical trial transparency.
Samina Hamilton, Aaron B Bernstein, Graham Blakey, Vivien Fagan, Tracy Farrow

Res Integr Peer Rev· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects.
Gilmour Morrison, Julie Crockett, Graham Blakey, Kenneth Sommerville

Clin Pharmacol Drug Dev· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical review of the TransCelerate Template for clinical study reports (CSRs) and publication of Version 2 of the CORE Reference (larity and penness in eporting: 3-based) Terminology Table.
Samina Hamilton, Aaron B Bernstein, Graham Blakey, Vivien Fagan, Tracy Farrow

Res Integr Peer Rev· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
Lesley Taylor, Barry Gidal, Graham Blakey, Bola Tayo, Gilmour Morrison

CNS Drugs· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
Lesley Taylor, Barry Gidal, Graham Blakey, Bola Tayo, Gilmour Morrison

CNS Drugs· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing the Clarity and Openness in Reporting: E3-based (CORE) Reference user manual for creation of clinical study reports in the era of clinical trial transparency.
Samina Hamilton, Aaron B Bernstein, Graham Blakey, Vivien Fagan, Tracy Farrow

Res Integr Peer Rev· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bayesian decision procedures for dose-escalation based on evidence of undesirable events and therapeutic benefit.
John Whitehead, Yinghui Zhou, John Stevens, Graham Blakey, Jim Price

Stat Med· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of a bayesian method of dose escalation based on bivariate binary responses.
John Whitehead, Yinghui Zhou, John Stevens, Graham Blakey

J Biopharm Stat· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis